Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Hiddo J Lambers Heerspink"'
Autor:
Bernard Zinman, Bruce Neal, George L Bakris, Vlado Perkovic, Meg J Jardine, Kris Rogers, Jie Yu, Adeera Levin, Dick de Zeeuw, Hong Zhang, Kenneth W Mahaffey, Clare Arnott, Rajiv Agarwal, Gian Luca Di Tanna, Carol Pollock, David C Wheeler, Christopher P Cannon, David M Charytan, Hiddo J Lambers Heerspink, Norman Rosenthal
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 11, Iss 3 (2023)
Introduction Relationships between glycemic-lowering effects of sodium glucose co-transporter 2 inhibitors and impact on kidney and cardiovascular outcomes are uncertain.Research design and methods We analyzed 4395 individuals with prebaseline and po
Externí odkaz:
https://doaj.org/article/83663dfd99b5429482efb801e4aa82d8
Autor:
Jan A J G van den Brand, Tjeerd M H Dijkstra, Jack Wetzels, Bénédicte Stengel, Marie Metzger, Peter J Blankestijn, Hiddo J Lambers Heerspink, Ron T Gansevoort
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216559 (2019)
Rationale & objectiveEarly prediction of chronic kidney disease (CKD) progression to end-stage kidney disease (ESKD) currently use Cox models including baseline estimated glomerular filtration rate (eGFR) only. Alternative approaches include a Cox mo
Externí odkaz:
https://doaj.org/article/d53b5705346f4c71a4c7de712584ede6
Autor:
Michelle J Pena, Andreas Heinzel, Georg Heinze, Alaa Alkhalaf, Stephan J L Bakker, Tri Q Nguyen, Roel Goldschmeding, Henk J G Bilo, Paul Perco, Bernd Mayer, Dick de Zeeuw, Hiddo J Lambers Heerspink
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0120995 (2015)
ObjectiveWe aimed to identify a novel panel of biomarkers predicting renal function decline in type 2 diabetes, using biomarkers representing different disease pathways speculated to contribute to the progression of diabetic nephropathy.Research desi
Externí odkaz:
https://doaj.org/article/f480f5fe01fb462c8321cc2866967d68
Autor:
Katarina Mirković, Carolina R C Doorenbos, Wendy A Dam, Hiddo J Lambers Heerspink, Maartje C J Slagman, Ferdau L Nauta, Andrea B Kramer, Ronald T Gansevoort, Jacob van den Born, Gerjan Navis, Martin H de Borst
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55887 (2013)
Non-invasive tubulointerstitial damage markers may allow better titration and monitoring of renoprotective therapy. We investigated the value of urinary vitamin D binding protein excretion (uVDBP) as a tubulointerstitial inflammation and fibrosis mar
Externí odkaz:
https://doaj.org/article/68c6f354370246a4b0432d0b83941842
Autor:
Darren K. McGuire, John P.H. Wilding, Marc S. Sabatine, Avivit Cahn, Thomas A Zelniker, Hiddo J. Lambers Heerspink, Lawrence A. Leiter, KyungAh Im, Itamar Raz, Deepak L. Bhatt, Erica L. Goodrich, Stephen D. Wiviott, Jamie P. Dwyer, Anna Maria Langkilde, Ofri Mosenzon, Ingrid Gause-Nilsson
Publikováno v:
JAMA Cardiol
Jama cardiology, 6(7), 811-819. AMER MEDICAL ASSOC
JAMA Cardiology
Jama cardiology, 6(7), 811-819. AMER MEDICAL ASSOC
JAMA Cardiology
ImportanceSodium-glucose cotransporter 2 inhibitors, such as dapagliflozin, promote renal glucose excretion and reduce cardiovascular (CV) deaths and hospitalizations for heart failure (HHF) among patients with type 2 diabetes. The relative CV effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acda1b28983c9bf5348058544f648478
https://doi.org/10.1001/jamacardio.2021.0660
https://doi.org/10.1001/jamacardio.2021.0660
Autor:
Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, Aliza Rozenberg, Gabriel Chodick, Johan Bodegård, Lawrence A. Leiter, Subodh Verma, Hiddo J. Lambers Heerspink, Avraham Karasik, Ofri Mosenzon
Publikováno v:
Cardiovascular Diabetology, 21(1):104. BioMed Central Ltd.
Background Type-2 diabetes (T2D), chronic kidney disease, and heart failure (HF) share epidemiological and pathophysiological features. Although their prevalence was described, there is limited contemporary, high-resolution, epidemiological data rega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c75c245bed87c4883a00615396b081
https://research.rug.nl/en/publications/8eb19fdf-ce1f-45d9-853e-e7a811dbf059
https://research.rug.nl/en/publications/8eb19fdf-ce1f-45d9-853e-e7a811dbf059
Autor:
Maaike K. van Gelder, J Roggeveld, Daan J Touw, Ron T. Gansevoort, Jasper Stevens, Claire C J Dekkers, Remco A. Koster, Mireille A. Wessels, Hiddo J. Lambers Heerspink
Publikováno v:
Bioanalysis, 12(14), 981-990. FUTURE SCI LTD
Aim: Iohexol plasma clearance is used as an indicator of kidney function in clinical and preclinical settings. To investigate the pharmacokinetic profile of iohexol, a rapid, simple method for measurement of iohexol in different matrices and species
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56ae0abe759b0b3d8fbb3cd192c5c4a2
https://research.rug.nl/en/publications/f73cc416-20a3-4f5c-b6b8-3b3b6b118b83
https://research.rug.nl/en/publications/f73cc416-20a3-4f5c-b6b8-3b3b6b118b83
Autor:
Harald Mischak, Justyna Siwy, Peter Rossing, Joost P. Schanstra, Lotte Jacobs, Raymond Vanholder, Claudia Pontillo, Joachim Jankowski, Jan A. Staessen, Petra Zürbig, Antonia Vlahou, Hiddo J. Lambers Heerspink, William Mullen
Publikováno v:
Nephrology Dialysis Transplantation, 32(9), 1510-1516. Oxford University Press
Pontillo, C, Jacobs, L, Staessen, J A, Schanstra, J P, Rossing, P, Heerspink, H J L, Siwy, J, Mullen, W, Vlahou, A, Mischak, H, Vanholder, R, Zuerbig, P & Jankowski, J 2017, ' A urinary proteome-based classifier for the early detection of decline in glomerular filtration ', Nephrology, Dialysis, Transplantation, vol. 32, no. 9, pp. 1510-1516 . https://doi.org/10.1093/ndt/gfw239
Nephrology, Dialysis, Transplantation, 32(9), 1510-1516. Oxford University Press
Pontillo, C, Jacobs, L, Staessen, J A, Schanstra, J P, Rossing, P, Heerspink, H J L, Siwy, J, Mullen, W, Vlahou, A, Mischak, H, Vanholder, R, Zuerbig, P & Jankowski, J 2017, ' A urinary proteome-based classifier for the early detection of decline in glomerular filtration ', Nephrology, Dialysis, Transplantation, vol. 32, no. 9, pp. 1510-1516 . https://doi.org/10.1093/ndt/gfw239
Nephrology, Dialysis, Transplantation, 32(9), 1510-1516. Oxford University Press
BACKGROUND: Chronic kidney disease (CKD) progression is currently assessed by a decline in estimated glomerular filtration rate (eGFR) and/or an increase in urinary albumin excretion (UAE). However, these markers are considered either to be late-stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e21b30ae736db57d25df3ad6dc63197
https://research.rug.nl/en/publications/dd6f6f88-28d8-4ea5-bca8-bafd19be1809
https://research.rug.nl/en/publications/dd6f6f88-28d8-4ea5-bca8-bafd19be1809
Autor:
Ann Maria Langkilde, Fan Fan Hou, Magnus Lindberg, C. David Sjöström, David C. Wheeler, Robert D. Toto, Ricardo Correa-Rotter, Bergur V. Stefánsson, John J.V. McMurray, Tom Greene, Peter Rossing, Hiddo J. Lambers Heerspink, Glenn M. Chertow
Publikováno v:
Journal of Cardiac Failure. 26:1111
Background Patients with chronic kidney disease (CKD) are at high risk of adverse renal and cardiovascular (CV) outcomes, particularly heart failure. We investigated the effects of dapagliflozin inpatients with CKD, with and without type 2 diabetes (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f74afa23c822f3479ad2435815bf7a0
https://doi.org/10.1016/j.cardfail.2020.11.024
https://doi.org/10.1016/j.cardfail.2020.11.024
Autor:
Charlotte A. Keyzer, Ido P. Kema, Ron T. Gansevoort, Hiddo J. Lambers-Heerspink, Stephan J. L. Bakker, Dick de Zeeuw, Petronella E. Deetman, Gerjan Navis, Michel M. Joosten, Martin H. de Borst
Publikováno v:
Clinical Journal of the American Society of Nephrology, 10(12), 2119-2127. AMER SOC NEPHROLOGY
Low circulating 25-hydroxyvitamin D [25(OH)D] and high sodium intake are both associated with progressive albuminuria and renal function loss in CKD. Both vitamin D and sodium intake interact with the renin-angiotensin-aldosterone system. We investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc2dd7e11ebd76b210378efcfc2b750
https://doi.org/10.2215/cjn.03830415
https://doi.org/10.2215/cjn.03830415